We served as lead healthcare regulatory counsel, as well as provided antitrust, employee benefits and tax support, for a leading provider of 340B Drug Pricing Program services in its acquisition by a prescription benefit management subsidiary (PBM) of a leading pharmacy healthcare provider.
Pharmacy Benefit Management Acquisition
You Also May Be Interested In:
Representing CargoSprint LLC in defending against an antitrust lawsuit brought by CargoSprint’s competitor, PayCargo LLC
We represented BioScrip, Inc. in its merger with Option Care Enterprises, Inc. The newly combined company, Option Care Health, Inc., emerges as the largest independent home and alternate site infusion services provider in the United States. Option Care Health’s common stock will be listed on the Nasdaq Global Select Market under the ticker symbol BIOS.